“…Solid lipid nanoparticle (SLN) systems appear to be an efficient approach for increasing the aqueous solubility and stability of drugs and decreasing the particle size to the nanoscale level. ,− In SLN systems, a lipophilic drug is stably dispersed in the water solvent by loading a lipid matrix of SLN via preparing an oil-in-water (O/W) phase. ,, The solid structure of the SLN system protects an unstable drug from environmental factors such as light, pH, and atmospheric moisture. − In particular, SLN can be delivered into the lymphatic system upon oral administration by bypassing the liver via forming chylomicrons in enterocytes. , Thus, drugs embedded in SLNs effectively avoid hepatic first-pass metabolism, enhancing the pharmacological effects of the drug. ,,, Moreover, this formulation can be used as a brain-targeted drug delivery system when absorbed into the systemic circulation, overcoming one of the most important challenges in pharmaceutical sciences. , Although the blood–brain barrier, a highly selective semipermeable border, protects the brain parenchyma against circulating toxins or pathogens, it allows the diffusion of hydrophobic molecules …”